GenScript Biotech, a global biotechnology leader in the life science, biologics manufacturing, synthetic biology, and cell therapies announced that its Life Sciences subsidiary, GenScript, has introduced a next generation DNA purification platform:
The AmMag™ Quatro Mini-1100. This new instrument complements the widely acclaimed AmMag Quatro Maxi-1400, providing comprehensive solutions for both mini- and maxi-scale plasmid purification.
The AmMag Quatro Mini-1100 delivers an advanced, fully automated solution for mini-scale plasmid purification, providing optimal yields and low endotoxin levels. Capable of processing up to 192 samples per run and handling volumes ranging from 1 to 10 mL, this high-throughput system ensures consistent, high-quality results with minimal endotoxin. Its versatility makes it ideal for a broad range of applications, including gene therapy research, vaccine development, CRISPR and gene editing, cell line development, synthetic biology, and more.
"The Mini-1100 launch signifies GenScript's dedication to expanding our portfolio of automated plasmid purification solutions," said Paul Wu, Vice President of R&D for GenScript's Catalog Products Division. "Building on the success of the automated Maxi-1400 scale system, this new system empowers researchers with flexible, scalable options tailored to their specific needs."
Since its debut, the AmMag product line has set new standards in plasmid purification, with its ability to process high volumes, while delivering consistent, high-quality results. The AmMag performance has been praised by researchers from many prominent biotechnology companies including TScan Therapeutics, Valent BioSciences, and Incyte highlighting its efficiency and reliability across cancer research, biopharmaceuticals, and sustainable agriculture.
With the addition of the AmMag Quatro Mini-1100, GenScript enhances its offerings to support modern research needs. Labs can now benefit from specialized systems for both mini- and maxi-preps, delivering high-quality, transfection-ready plasmid DNA.